Skip to main content
Equibles
BTMD logo

BTMD · biote Corp. · Earnings Call Transcripts & Audio

Track BTMD — free

Use BTMD with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research BTMD.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$1.33 -0.04 (-2.57%) At close · Sep 21
Rebalance outlook locked
Market Cap
$48.86M
Shares
35.93M

biote Corp. Earnings Call Transcripts

Quarterly earnings calls for biote Corp. (BTMD), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▲18% $41.97M $15,000 '22 Q3 22-11-08 · $44.48M $447,518 '22 Q4 23-03-28 ▲20.7% $44.84M −$6.80M '23 Q1 23-05-09 ▲19.1% $49.26M −$5.14M '23 Q2 23-08-10 ▲8.5% $45.56M $7.53M '23 Q3 23-11-07 ▲2.7% $45.70M $7.73M '23 Q4 24-03-12 ▲4.4% $46.80M −$4.16M '24 Q1 24-05-07 ▼0.2% $49.17M −$7.09M '24 Q2 24-08-08 ▲12.8% $51.38M $10.70M '24 Q3 24-11-12 ▲9% $49.83M $3.70M '24 Q4 25-03-12 ▲4.7% $48.99M $13.72M '25 Q1 25-05-07 ▼0.6% $48.86M $3.19M '25 Q2 25-08-06 ▼6.7% $47.96M $8.19M '25 Q3 25-11-05 ▼6.9% $46.41M $1.95M '25 Q4 26-03-11 ▼8.3% $44.94M $2.28M '26 Q1 26-05-06 LATEST ▼9.5% $44.23M −$6.56M '26 Q2 26-08-05
Earnings call
FY26 · Q2
2026-08-05
biote Corp. (BTMD) Q2 2026 Earnings Call Transcript
Cautious tone Voluntary recall and supply normalization Procedure revenue recovery and clinic volume Legal expenses and settlements
Revenue
$44.23M
▼ 9.5% YoY
Diluted EPS
$-0.23
▼ 330% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-05-06
biote Corp. (BTMD) Q1 2026 Earnings Call Transcript
Cautious tone Voluntary product recall Asteria Health production recovery Revenue and procedure volume
Revenue
$44.94M
▼ 8.3% YoY
Diluted EPS
$0.06
▼ 83.8% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-03-11
biote Corp. (BTMD) Q4 2025 Earnings Call Transcript
Positive tone Procedure revenue decline Voluntary product recall New clinic and practitioner growth
Revenue
$46.41M*
▼ 6.9% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-05
biote Corp. (BTMD) Q3 2025 Earnings Call Transcript
Balanced tone Commercial team rebuild Practitioner network and marketing event Procedure revenue decline
Revenue
$47.96M
▼ 6.7% YoY
Diluted EPS
$0.22
▼ 33.3% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-06
biote Corp. (BTMD) Q2 2025 Earnings Call Transcript
Cautious tone Procedure revenue softness and restructuring New clinic additions and attrition Adjusted EBITDA and profitability
Revenue
$48.86M
▼ 0.6% YoY
Diluted EPS
$0.10
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-07
biote Corp. (BTMD) Q1 2025 Earnings Call Transcript
Positive tone Procedure Revenue Decline and Recovery Commercial Restructuring and Reorganization Gross Margin Expansion from 503B Vertical Integration
Revenue
$48.99M
▲ 4.7% YoY
Diluted EPS
$0.37
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-03-12
biote Corp. (BTMD) Q4 2024 Earnings Call Transcript
Positive tone Clinical decision support software (CDSS) transition Practitioner network expansion 2025 financial outlook
Revenue
$49.83M*
▲ 9% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-12
biote Corp. (BTMD) Q3 2024 Earnings Call Transcript
Positive tone Procedures and Clinical Decision Support software 2025 outlook and growth drivers Vertical integration / Asteria Health manufacturing
Revenue
$51.38M
▲ 12.8% YoY
Diluted EPS
$0.33
▲ 37.5% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-08
biote Corp. (BTMD) Q2 2024 Earnings Call Transcript
Positive tone Gross margin and profitability outlook BioteRx platform enhancements and rollout Asteria Health integration and licensing
Revenue
$49.17M
▼ 0.2% YoY
Diluted EPS
$-0.21
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-07
biote Corp. (BTMD) Q1 2024 Earnings Call Transcript
Positive tone BioteRx product launch Procedure revenue growth Practitioner training and onboarding
Revenue
$46.80M
▲ 4.4% YoY
Diluted EPS
$-0.12
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-03-12
biote Corp. (BTMD) Q4 2023 Earnings Call Transcript
Positive tone 2024 outlook and guidance BioteRx wellness launch Sales force optimization and practitioner network
Revenue
$45.70M*
▲ 2.7% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-07
biote Corp. (BTMD) Q3 2023 Earnings Call Transcript
Revenue
$45.56M
▲ 8.5% YoY
Diluted EPS
$0.24
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-10
biote Corp. (BTMD) Q2 2023 Earnings Call Transcript
Revenue
$49.26M
▲ 19.1% YoY
Diluted EPS
$-0.25
Rev · 7q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-09
biote Corp. (BTMD) Q1 2023 Earnings Call
Revenue
$44.84M
▲ 20.7% YoY
Diluted EPS
$-0.39
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-03-28
biote Corp. (BTMD) Q4 2022 Earnings Call
Revenue
$44.48M*
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-08
biote Corp. (BTMD) Q3 2022 Earnings Call
Revenue
$41.97M
▲ 18% YoY
Diluted EPS
$0.00
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-10
biote Corp. (BTMD) Q2 2022 Earnings Call
Revenue
$41.36M
▲ 19% YoY
Diluted EPS
$-0.34
Rev · 4q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–17 of 17 earnings calls
Key facts CIK 1819253 CUSIP 090683103 13F (30d) 1 filings 1 filers Visit website Investor relations